Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janne Kaergaard Mortensen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
CNS Drugs|September 19, 2018
Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after StrokeJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Pharmacotherapy|February 3, 2021
Pharmacological management of post-stroke depression: an update of the evidence and clinical guidanceJanne Kaergaard Mortensen, Grethe Andersen
Stroke|July 3, 2020
Closing the Age Gap in Acute Ischemic Stroke TreatmentJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Drug Safety|September 27, 2021
Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular riskJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Drug Safety|April 4, 2015
Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patientsJanne Kaergaard Mortensen, Grethe Andersen
Stroke|June 5, 2014
Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortalityJanne Kaergaard Mortensen, Heidi Larsson, Søren Paaske Johnsen, et al.
Stroke|January 12, 2013
Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up studyJanne Kaergaard Mortensen, Heidi Larsson, Søren Paaske Johnsen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2015
Early Antidepressant Treatment and All-Cause 30-Day Mortality in Patients with Ischemic StrokeJanne Kaergaard Mortensen, Søren Paaske Johnsen, Heidi Larsson, et al.
European Journal of Neurology|November 20, 2024
Trajectories of physical activity after ischaemic stroke: Exploring prediction of changeAndreas Gammelgaard Damsbo, Rolf Ankerlund Blauenfeldt, Grethe Andersen, et al.
Scientific Reports|December 29, 2019
Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind studyKristian Lundsgaard Kraglund, Janne Kaergaard Mortensen, Søren Paaske Johnsen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
CNS Drugs|September 19, 2018
Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after StrokeJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Pharmacotherapy|February 3, 2021
Pharmacological management of post-stroke depression: an update of the evidence and clinical guidanceJanne Kaergaard Mortensen, Grethe Andersen
Stroke|July 3, 2020
Closing the Age Gap in Acute Ischemic Stroke TreatmentJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Drug Safety|September 27, 2021
Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular riskJanne Kaergaard Mortensen, Grethe Andersen
Expert Opinion on Drug Safety|April 4, 2015
Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patientsJanne Kaergaard Mortensen, Grethe Andersen
Stroke|June 5, 2014
Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortalityJanne Kaergaard Mortensen, Heidi Larsson, Søren Paaske Johnsen, et al.
Stroke|January 12, 2013
Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up studyJanne Kaergaard Mortensen, Heidi Larsson, Søren Paaske Johnsen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2015
Early Antidepressant Treatment and All-Cause 30-Day Mortality in Patients with Ischemic StrokeJanne Kaergaard Mortensen, Søren Paaske Johnsen, Heidi Larsson, et al.
European Journal of Neurology|November 20, 2024
Trajectories of physical activity after ischaemic stroke: Exploring prediction of changeAndreas Gammelgaard Damsbo, Rolf Ankerlund Blauenfeldt, Grethe Andersen, et al.
Scientific Reports|December 29, 2019
Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind studyKristian Lundsgaard Kraglund, Janne Kaergaard Mortensen, Søren Paaske Johnsen, et al.
Pageof 3